FIELD: medicine, gastroenterology. SUBSTANCE: the method deals with restoring a closing function of ileocecal valve due to treatment with magnesium orotate indicated perorally at the dosage of 1.0 g thrice daily for 3 months, then at the dosage of 0.5 g thrice daily for the period of the next 3 months. The method enables to conduct therapy at excluding the necessity of operative interference. EFFECT: higher efficiency of therapy.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSIS OF ORIGINAL DEFICIENCY OF BAUHIN'S VALVE | 1999 |
|
RU2150110C1 |
METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1999 |
|
RU2184495C2 |
METHOD OF NORMALIZATION OF ENDOGENOUS HYPOCORTICOIDISM STATE | 1995 |
|
RU2131279C1 |
METHOD FOR CREATING ILEOCECAL CLOSING APPARATUS (ILEOCECAL VALVE) | 2003 |
|
RU2253378C2 |
METHOD FOR CORRECTION OF NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA | 2005 |
|
RU2290175C2 |
THERAPY OF MITOCHONDRIAL INSUFFICIENCY IN UNDIFFERENTIATED FORMS OF CONNECTIVE TISSUE DYSPLASIA IN CHILDREN | 2006 |
|
RU2379038C2 |
METHOD FOR TREATING PATIENTS WITH LOW UNDEVELOPED DISENGAGED SMALL INTESTINAL FISTULAS | 2002 |
|
RU2213527C1 |
METHOD FOR CREATING ILEOCECAL VALVE (BAUHIN'S VALVE) | 2002 |
|
RU2225173C2 |
METHOD OF AGE-SPECIFIC THERAPY AND PREVENTION OF CONNECTIVE TISSUE DYSPLASIA | 2016 |
|
RU2657751C1 |
METHOD OF BAUHINOPLASTY | 1991 |
|
RU2026641C1 |
Authors
Dates
2002-08-20—Published
2000-07-10—Filed